ERYTECH PHARMA (ERYP.PA)
FR0011471135 - Common Stock
ChartMill assigns a Buy % Consensus number of 42% to ERYP.PA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.67. This target is 358.43% above the current price.
ERYP.PA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about ERYP.PA.
In the previous month the buy percentage consensus was at a similar level.
ERYP.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.